The Paradoxical Relationship Between Nicotine and SARS-CoV-2 Infection: A Systematic Review

Maliha Majeed; Gregory Lewis; Catherine Olang; Sasha Lake; Vasavi Gorantla

doi:10.26452/ijrps.v13i1.26

Maliha Majeed ⁽¹⁾ , Gregory Lewis ⁽²⁾ , Catherine Olang ⁽³⁾ , Sasha Lake ⁽⁴⁾ , Vasavi Gorantla ⁽⁵⁾

(1) Department of Anatomical Sciences, St. George’s University School of Medicine, Grenada, West Indies, Grenada ,

(2) Department of Anatomical Sciences, St. George’s University School of Medicine, Grenada, West Indies, Grenada ,

(3) Department of Anatomical Sciences, St. George’s University School of Medicine, Grenada, West Indies, Grenada ,

(4) Department of Anatomical Sciences, St. George’s University School of Medicine, Grenada, West Indies, Grenada ,

(5) Department of Anatomical Sciences, St. George’s University School of Medicine, Grenada, West Indies, Grenada

https://doi.org/10.26452/ijrps.v13i1.26

Issue
Vol. 13 No. 1 (2022): Volume 13 Issue 1

Keywords:

COVID-19, SARS-CoV-2, Smoking, Nicotine, ACE-2

PDF LaTeX HTML ePUB

Abstract

Across the board, smoking is considered to be negative toward our health. While this information has been known for a relatively long time, the COVID-19 pandemic has stirred up a controversial idea: that smokers are protected from severe COVID-19 relative to non-smokers. This suggests that smoking is a helpful agent in the evolving fight against SARS-CoV-2, and impressionable individuals are at risk of starting to smoke as a means of protecting themselves from the virus. To address the validity of this claim, a systematic review was done according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. PubMed was searched for relevant articles and the results were screened according to inclusion criteria. Our search yielded a total of 81 results and after removal of duplicates, non-English papers, and a quality appraisal a total of 16 papers were included in this review. We found that while smokers were more likely present with a less severe disease due to downregulation of severe cytokine storm, they were overall more likely to contract COVID-19 due to upregulation of ACE-2 receptors which SARS-CoV-2 uses to enter the cells of the respiratory epithelium. Also, long time smokers who develop COPD are more likely to have fatal outcomes from COVID-19 infection. Further, these results were due to the effects of nicotine and not cigarettes themselves. Since cigarettes contain numerous carcinogens, they are not recommended as a prophylaxis for COVID-19. However, we recommend that nicotine should be a topic for further research as potential therapy.

Full text article

Generated from XML file

References

Jesus González-Rubio, Carmen Navarro-López, Elena López-Nájera, Ana López-Nájera, Lydia Jiménez-Díaz, Juan D. Navarro-López, and Alberto Nájera. A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19. International journal of environmental research and public health, 17(20):7394, 2020.

Jaber S. Alqahtani, Tope Oyelade, Abdulelah M. Aldhahir, Saeed M. Alghamdi, Mater Almehmadi, Abdullah S. Alqahtani, Shumonta Quaderi, Swapna Mandal, and John R. Hurst. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PloS one, 15(5):e0233147, 2020.

Silvia Helena de Carvalho Sales-Peres, Lucas José de Azevedo-Silva, Rafaela Carolina Soares Bonato, Matheus de Carvalho Sales-Peres, Ana Carolina da Silvia Pinto, and Joel Ferreira Santiago Junior. Coronavirus (SARS-CoV-2) and the risk of obesity for critically illness and ICU admitted: Meta-analysis of the epidemiological evidence. Obesity research and clinical practice, 14(5):389–397, 2020.

Konstantinos Farsalinos, Anastasia Barbouni, and Raymond Niaura. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Internal and emergency medicine, 15(5):845–852, 2020.

Adinat Umnuaypornlert, Sukrit Kanchanasurakit, Don Eliseo III Lucero-Prisno, and Surasak Saokaew. Smoking and risk of negative outcomes among COVID-19 patients: A systematic review and meta-analysis. Tobacco induced dis- eases, 19:09, 2021.

Konstantinos Farsalinos, Pantelis G. Bagos, Theodoros Giannouchos, Raymond Niaura, Anastasia Barbouni, and Konstantinos Poulas. Smoking prevalence among hospitalized COVID-19 patients and its association with disease severity and mortality: an expanded re-analysis of a recent publication. Harm Reduction Journal, 18(1):1–9, 2021.

Konstantinos Farsalinos, Anastasia Barbouni, Konstantinos Poulas, Riccardo Polosa, Pasquale Caponnetto, and Raymond Niaura. Current smoking, former smoking, and adverse outcome among hospitalized COVID- 19 patients: a systematic review and meta- analysis. Therapeutic advances in chronic disease, 11:1–14, 2020.

Askin Gülsen, Burcu Arpinar Yigitbas, Berat Uslu, Daniel Drömann, and Oguz Kilinc. The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta- Analysis. Pulmonary medicine, pages 1–11, 2020.

Matthew J Page, Joanne E McKenzie, Patrick M Bossuyt, Isabelle Boutron, Tammy C Hoffmann, Cynthia D Mulrow, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372:n71, 2021.

Emily Banks, Grace Joshy, Rosemary J. Korda, Bill Stavreski, Kay Soga, Sam Egger, Cathy Day, Naomi E. Clarke, Sarah Lewington, and Alan D. Lopez. Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study. BMC medicine, 17(1):128, 2019.

Polina Kuznetsova. Smoking as a factor of reduced life expectancy in Russia. Demographic Survey, 6(5):141–161, 2020.

Peter N. Lee, Barbara A. Forey, Alison J. Thorn- ton, and Katharine J. Coombs. The relationship of cigarette smoking in Japan to lung cancer, COPD, ischemic heart disease and stroke: A systematic review. F1000Research, 7:204, 2018.

B Pan, X Jin, L Jun, S Qiu, Q Zheng, and M Pan. The relationship between smoking and stroke: A meta-analysis. Medicine, 98(12):e14872, 2019.

Ahmad M. AL-Bashaireh, Linda G. Haddad, Michael Weaver, Debra Lynch Kelly, Xing Chengguo, and Saunjoo Yoon. The Effect of Tobacco Smoking on Musculoskeletal Health: A Systematic Review. Journal of environmental and public health, page 4184190, 2018.

Zhen-Jie Wu, Peng Zhao, Bin Liu, and Zhen- Chao Yuan. Effect of Cigarette Smoking on Risk of Hip Fracture in Men: A Meta-Analysis of 14 Prospective Cohort Studies. PloS one, 11(12):e0168990, 2016.

Jessica H. Heyer, Dana A. Perim, Richard L. Amdur, and Rajeev Pandarinath. Impact of smoking on outcomes following knee and shoulder arthroscopy. European journal of Orthopaedic Surgery and Traumatology, 30(2):329–336, 2020.

Meredith S. Duncan, Matthew S. Freiberg, Robert A. Greevy Jr, Suman Kundu, Ramachandran S. Vasan, and Hilary A. Tindle. Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease. JAMA, 322(7):642– 650, 2019.

Manish S. Patel and Michael B. Steinberg. Smoking Cessation. Annals of Internal Medicine, 164(5), 2016.

Erika Litvin Bloom, Haruka Minami, Richard A. Brown, David R. Strong, Deborah Riebe, and Ana M. Abrantes. Quality of life after quitting smoking and initiating aerobic exercise. Psychology, Health and Medicine, 22(9):1127– 1135, 2017.

Tao Zhang, Wei-Sen Huang, Weijie Guan, Ziying Hong, Jiabo Gao, Guoying Gao, Guofeng Wu, and Yin-Yin Qin. Risk factors and predictors associated with the severity of COVID-19 in China: a systematic review, meta-analysis, and meta-regression. Journal of thoracic disease, 12(12):7429–7441, 2020.

Shaghayegh Haghjooy Javanmard, Kiyan Heshmat-Ghahdarijani, and Golnaz Vaseghi. Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox. Infection control and hospital epidemiology, 42(1):118–119, 2021.

James L. Olds and Nadine Kabbani. Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? The FEBS journal, 287(17):3651–3655, 2020.

Joshua M. Oakes, Robert M. Fuchs, Jason D. Gardner, Eric Lazartigues, and Xinping Yue. Nicotine and the renin-angiotensin system. American journal of physiology. Regulatory, integrative and comparative physiology, 315(5):R895–R906, 2018.

Jia Li, Xue He, Yuan Yuan, Chunyan Guan, Zifen Gao, and Gehong Dong. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) pneumonia. American Journal of Infection Control, 49(1):82–89, 2021.

Zhaohai Zheng, Fang Peng, Buyun Xu, Jingjing Zhao, Huahua Liu, Jiahao Peng, Qingsong Li, Chongfu Jiang, Yan Zhou, Shuqing Liu, Chunji Ye, Peng Zhang, Yangbo Xing, Hangyuan Guo, and Weiliang Tang. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. The Journal of infection, 81(2):e16–e25, 2020.

Roengrudee Patanavanich and Stanton A Glantz. Smoking Is Associated With COVID-19 Progression: A Meta-analysis. Nicotine and Tobacco Research, 22(9):1653–1656, 2020.

Qianwen Zhao, Meng Meng, Rahul Kumar, Yin- lian Wu, Jiaofeng Huang, Ningfang Lian, Yun- lei Deng, and Su Lin. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. Journal of medical virology, 92(10):1915–1921, 2020.

Francesco Del Sole, Alessio Farcomeni, Lorenzo Loffredo, Roberto Carnevale, Danilo Menichelli, Tommasa Vicario, Pasquale Pignatelli, and Daniele Pastori. Features of severe COVID-19: A systematic review and meta-analysis. European journal of clinical investigation, 50(10):e13378, 2020.

A Emami, F Javanmardi, N Pirbonyeh, and A Akbari. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Archives of academic emergency medicine, 8(1):e35, 2020.

Diana C. Sanchez-Ramirez and Denise Mackey. Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis. Respiratory medicine, 171:106096, 2020.

Arthur Eumann Mesas, Iván Cavero-Redondo, Celia Álvarez Bueno, Marcos Aparecido Sarriá Cabrera, Selma Maffei de Andrade, Irene Sequí- Dominguez, and Vicente Martínez-Vizcaíno. Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and metaanalysis exploring differences by age, sex and health conditions. PloS one, 15(11):e0241742, 2020.

Kunchok Dorjee, Hyunju Kim, Elizabeth Bonomo, and Rinchen Dolma. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta- analysis of 77 studies and 38,000 patients. PloS one, 15(12):e0243191, 2020.

Antonios Karanasos, Konstantinos Aznaouridis, George Latsios, Andreas Synetos, Stella Plitaria, Dimitrios Tousoulis, and Konstantinos Toutouzas. Impact of Smoking Status on Disease Severity and Mortality of Hospitalized Patients With COVID-19 Infection: A Systematic Review and Meta-analysis. Nicotine and tobacco research, 22(9):1657–1659, 2020.

Janice M. Leung, Chen X. Yang, Anthony Tam, Tawimas Shaipanich, Tillie-Louise Hackett, Gurpreet K. Singhera, Delbert R. Dorscheid, and Don D. Sin. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. The European respiratory journal, 55(5):2000688, 2020.

Patrizia Russo, Stefano Bonassi, Robertina Giacconi, Marco Malavolta, Carlo Tomino, and Fabrizio Maggi. COVID-19 and smoking: is nicotine the hidden link? The European respiratory journal, 55(6):2001116, 2020.

Janice M. Leung, Chen Xi Yang, and Don D. Sin. COVID-19 and nicotine as a mediator of ACE-2. The European respiratory journal, 55(6):2001261, 2020.

Qixin Wang, Isaac K. Sundar, Dongmei Li, Joseph H. Lucas, Thivanka Muthumalage, Samantha R. McDonough, and Irfan Rahman. E-cigarette-induced pulmonary inflammation and dysregulated repair are mediated by nAChR α7 receptor: role of nAChR α7 in SARS- CoV-2 Covid-19 ACE2 receptor regulation. Respiratory research, 21(1):154, 2020.

Sabrina Rahman Archie and Luca Cucullo. Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping? International journal of molecular sciences, 21(11):3916, 2020.

Arjun Gurmeet Singh and Pankaj Chaturvedi. Tobacco use and vaping in the COVID-19 era. Head and neck, 42(6):1240–1242, 2020.

Emilie Javelle. Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic. Archives of toxicology, 94(6):2261–2262, 2020.

Shivani Mathur Gaiha, Jing Cheng, and Bonnie Halpern-Felsher. Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19. Journal of Adolescent Health, 67(4):519– 523, 2020.

Shiwei Kang, Xiaowei Gong, and Yadong Yuan. Association of smoking and cardiovascular disease with disease progression in COVID-19: a systematic review and meta-analysis. Epidemiology and infection, 149:1–26, 2021.

Manpreet Sukhija, Reena Srivastava, and Aditya Kaushik. Pharmacokinetic characterization of three novel 4-mg nicotine lozenges. International journal of clinical pharmacology and therapeutics, 56(3):113–119, 2018.